Linxin Xu

1.2k total citations · 1 hit paper
23 papers, 894 citations indexed

About

Linxin Xu is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Linxin Xu has authored 23 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Linxin Xu's work include Adipose Tissue and Metabolism (6 papers), Pancreatic function and diabetes (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Linxin Xu is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Pancreatic function and diabetes (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Linxin Xu collaborates with scholars based in China, United States and Japan. Linxin Xu's co-authors include Liming Chen, Mei Xue, Bei Sun, Xiaochen Yu, Ying Cheng, Yunhong Lu, Xiangyang Liu, Xiaoyu Li, Jie Zhang and Ting Li and has published in prestigious journals such as PLoS ONE, Medicine and Metabolism.

In The Last Decade

Linxin Xu

22 papers receiving 885 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

2019 442 citations Chenguang Li, Jie Zhang et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linxin Xu China	11	433	362	272	265	117	23	894
Yunhong Lu China	8	395 0.9×	393 1.1×	252 0.9×	254 1.0×	95 0.8×	12	917
Ornella Carbonara Italy	15	383 0.9×	324 0.9×	189 0.7×	385 1.5×	101 0.9×	22	998
Mathias Burgmaier Germany	20	283 0.7×	265 0.7×	420 1.5×	354 1.3×	82 0.7×	55	1.0k
Xiaohan Lu United States	22	530 1.2×	433 1.2×	203 0.7×	556 2.1×	65 0.6×	55	1.3k
Takeyoshi Murano Japan	24	418 1.0×	292 0.8×	334 1.2×	347 1.3×	209 1.8×	52	1.2k
Fone‐Ching Hsiao Taiwan	18	256 0.6×	241 0.7×	161 0.6×	133 0.5×	165 1.4×	42	848
Hirofumi Kurokawa Japan	13	317 0.7×	200 0.6×	170 0.6×	327 1.2×	66 0.6×	22	770
Xiangyang Liu China	10	360 0.8×	269 0.7×	296 1.1×	249 0.9×	38 0.3×	34	770
Laween Uthman Netherlands	10	811 1.9×	435 1.2×	463 1.7×	384 1.4×	45 0.4×	16	1.1k
Motofumi Sasaki Japan	13	334 0.8×	202 0.6×	177 0.7×	139 0.5×	87 0.7×	16	781

Countries citing papers authored by Linxin Xu

Since Specialization

Citations

This map shows the geographic impact of Linxin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxin Xu more than expected).

Fields of papers citing papers by Linxin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linxin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxin Xu. The network helps show where Linxin Xu may publish in the future.

Co-authorship network of co-authors of Linxin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Linxin Xu. A scholar is included among the top collaborators of Linxin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linxin Xu. Linxin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Liang, Xiaoyu Li, Yi Ren, et al.. (2025). The correlation between serum asprosin and type 2 diabetic patients with obesity in the community. Frontiers in Endocrinology. 16. 1535668–1535668. 2 indexed citations

Liu, Yunfeng, et al.. (2024). Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study. BMC Endocrine Disorders. 24(1). 27–27. 7 indexed citations

Wu, Qianqian, et al.. (2024). The relationship between 25-hydroxy vitamin D and serum asprosin in patients with type 2 diabetes in the community. Frontiers in Endocrinology. 15. 1409156–1409156.

Li, Xiaoyu, Xiangyang Liu, Linxin Xu, et al.. (2023). Integrin β6 mediates epithelial–mesenchymal transition in diabetic kidney disease. Molecular and Cellular Endocrinology. 572. 111955–111955. 3 indexed citations

Zhang, Jiaxin, Ziang Liu, Linxin Xu, et al.. (2023). Glucose metabolism profile recorded by flash glucose monitoring system in patients with hypopituitarism during prednisone replacement. World Journal of Diabetes. 14(7). 1112–1125. 1 indexed citations

Yu, Xiaochen, Ziyu Meng, Ting Fang, et al.. (2022). Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway. Frontiers in Physiology. 13. 817542–817542. 12 indexed citations

Xu, Linxin, et al.. (2022). Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1877–1884. 10 indexed citations

Li, Ting, Ting Fang, Linxin Xu, et al.. (2021). Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro. Frontiers in Pharmacology. 11. 622153–622153. 21 indexed citations

Xu, Linxin, Chaofei Xu, Xiaoyu Li, et al.. (2021). Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes. Frontiers in Physiology. 12. 745058–745058. 24 indexed citations

10.

Liu, Yunfeng, Jing Yang, Linxin Xu, et al.. (2020). <p>Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report</p>. International Journal of General Medicine. Volume 13. 825–831. 2 indexed citations

11.

Li, Xiaoyu, Rong Xu, Xiangyang Liu, et al.. (2020). Urinary miR‐3137 and miR‐4270 as potential biomarkers for diabetic kidney disease. Journal of Clinical Laboratory Analysis. 34(12). e23549–e23549. 4 indexed citations

12.

Liu, Xiangyang, Rong Xu, Linxin Xu, et al.. (2020). Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial. Annals of Translational Medicine. 8(8). 530–530. 13 indexed citations

13.

Liu, Xiangyang, Chaofei Xu, Linxin Xu, et al.. (2020). Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway. Metabolism. 111. 154334–154334. 98 indexed citations

14.

Xue, Mei, Ting Li, Yue Wang, et al.. (2019). Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice. Clinical Science. 133(15). 1705–1720. 85 indexed citations

15.

Li, Chenguang, Jie Zhang, Mei Xue, et al.. (2019). SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovascular Diabetology. 18(1). 15–15. 442 indexed citations breakdown →

16.

Li, Xiaoyu, Ting Li, Ying Cheng, et al.. (2019). Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta‐analysis. Diabetes/Metabolism Research and Reviews. 35(7). e3170–e3170. 51 indexed citations

17.

Xu, Linxin, Yi Ren, Jing Yang, et al.. (2018). Analysis of endocrine hormone metabolism level in a Chinese patient with mucopolysaccharidosis IVA. Medicine. 97(38). e12393–e12393. 2 indexed citations

18.

Ren, Yi, Linxin Xu, Yunfeng Liu, et al.. (2018). A novel 55-basepair deletion of hydroxymethylbilane synthase gene found in a Chinese patient with acute intermittent porphyria and her family. Medicine. 97(37). e12295–e12295. 4 indexed citations

19.

Li, Ge, Linxin Xu, Yanglu Zhao, et al.. (2017). Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study. PLoS ONE. 12(10). e0186222–e0186222. 40 indexed citations

20.

Liu, Sixuan, et al.. (2014). Effects of berberine on inflammatory cytokines induced by lipopolysaccharide in THP-1 cells. 34(4). 233–236. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact